Olverembatinib for 8p11 myeloproliferative syndrome with a positive BCR-FGFR1 fusion gene: a case report
Abstract 8p11 myeloproliferative syndrome (EMS) is a rare aggressive hematologic malignancy with a poor prognosis that can rapidly develop into acute leukemia. It is characterized by the translocation of fibroblast growth factor receptor-1 (FGFR1), and there is still a lack of effective and reliable...
Gespeichert in:
| Hauptverfasser: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Springer
2025-12-01
|
| Schriftenreihe: | Annals of Hematology |
| Schlagworte: | |
| Online-Zugang: | https://doi.org/10.1007/s00277-025-06522-8 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|